A Three-Case Series of Thrombotic Deaths in Patients over 50 with Comorbidities Temporally after modRNA COVID-19 Vaccination

Coronavirus disease 2019 (COVID-19) is the most dramatic pandemic of the new millennium; to counteract it, specific vaccines have been launched in record time under emergency use authorization or conditional marketing authorization by virtue of a favorable risk/benefit balance. Among the various tec...

Descripción completa

Detalles Bibliográficos
Autores principales: Roncati, Luca, Manenti, Antonio, Corsi, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032304/
https://www.ncbi.nlm.nih.gov/pubmed/35456110
http://dx.doi.org/10.3390/pathogens11040435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032304/
https://www.ncbi.nlm.nih.gov/pubmed/35456110
http://dx.doi.org/10.3390/pathogens11040435

Ejemplares similares